Twenty-five thousand lawsuits were settled this week between Bayer and Janssen pharmaceutical companies, and patients alleging that they were not adequately warned about the risks of life-altering complications regarding blood thinner medication, Xarelto.

Lawsuits dating back to 2014, which were consolidated in federal court in New Orleans, involved claims that patients were not adequately informed of the risks of life-threatening complications associated with Xarelto including internal bleeding, stroke, and death. Attorneys for the plaintiffs called the settlement a “fair and just resolution,” while a spokeswoman for Janssen reminded that the settlement included, “no admission of liability.”

In their statement, plaintiffs’ attorneys also said that in addition to addressing lawsuits that are already a part of the multi-district litigation, the settlement agreement resolves claims filed by April 4th. Currently, there is no estimate on how much each individual plaintiff will receive, but payments will be reduced for those whole filed claims after December 1, 2015, and for those who first suferred a Xarelto-related injury on or after March 1, 2016.

New Jersey and Philadelphia Personal Injury Lawyers

The Philadelphia personal injury lawyers at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of personal injury lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you or a loved one have suffered an injury as a result of a defective pharmaceutical drug product or any other type of personal injury, contact the personal injury lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.